loadpatents
Patent applications and USPTO patent grants for Cleemann; Felix.The latest application filed is for "cnp prodrugs with large carrier moieties".
Patent | Date |
---|---|
Cnp Prodrugs With Large Carrier Moieties App 20220296682 - Rau; Harald ;   et al. | 2022-09-22 |
CNP prodrugs with carrier attachment at the ring moiety Grant 11,413,351 - Rau , et al. August 16, 2 | 2022-08-16 |
Controlled-release CNP agonists with reduced side-effects Grant 11,389,511 - Sprogoe , et al. July 19, 2 | 2022-07-19 |
Controlled-release CNP agonists with low initial NPR-B activity Grant 11,389,510 - Sprogoe , et al. July 19, 2 | 2022-07-19 |
Controlled-release Cnp Agonists With Low Npr-c Binding App 20220211817 - Rau; Harald ;   et al. | 2022-07-07 |
Controlled-release CNP agonists with low NPR-C binding Grant 11,311,604 - Rau , et al. April 26, 2 | 2022-04-26 |
Liquid Pharmaceutical Formulations of PTH Conjugates App 20220088149 - SKANDS; Anja R.H. ;   et al. | 2022-03-24 |
Controlled-release Cnp Agonists With Increased Nep Stability App 20220088206 - SPROGOE; Kennett ;   et al. | 2022-03-24 |
PTH Prodrugs App 20220008516 - Sprogoe; Kennett ;   et al. | 2022-01-13 |
CNP prodrugs with large carrier moieties Grant 11,154,593 - Rau , et al. October 26, 2 | 2021-10-26 |
Cnp Prodrugs With Large Carrier Moieties App 20210177942 - Rau; Harald ;   et al. | 2021-06-17 |
Cnp Prodrugs With Large Carrier Moieties App 20210077584 - Rau; Harald ;   et al. | 2021-03-18 |
Cnp Prodrugs App 20210069339 - Sprogoe; Kennett ;   et al. | 2021-03-11 |
Pth Prodrugs App 20200376089 - Sprogoe; Kennett ;   et al. | 2020-12-03 |
Pth Prodrugs App 20200360487 - Sprogoe; Kennett ;   et al. | 2020-11-19 |
CNP prodrugs with large carrier moieties Grant 10,835,578 - Rau , et al. November 17, 2 | 2020-11-17 |
PTH Prodrugs App 20200276276 - Sprogoe; Kennett ;   et al. | 2020-09-03 |
Controlled-release Cnp Agonists With Low Initial Npr-b Activity App 20190328840 - SPROGOE; Kennett ;   et al. | 2019-10-31 |
Controlled-release Cnp Agonists With Reduced Side-effects App 20190328841 - Sprogoe; Kennett ;   et al. | 2019-10-31 |
Cnp Prodrugs App 20190255183 - Sprogoe; Kennett ;   et al. | 2019-08-22 |
Cnp Prodrugs With Large Carrier Moieties App 20190015481 - Rau; Harald ;   et al. | 2019-01-17 |
Cnp Prodrugs With Carrier Attachment At The Ring Moiety App 20190008977 - Rau; Harald ;   et al. | 2019-01-10 |
Controlled-release Cnp Agonists With Low Npr-c Binding App 20190000926 - Rau; Harald ;   et al. | 2019-01-03 |
Cnp Prodrugs App 20170368189 - SPROGOE; Kennett ;   et al. | 2017-12-28 |
Prodrugs Comprising an Aminoalkyl Glycine Linker App 20170224829 - BISEK; Nicola ;   et al. | 2017-08-10 |
Relaxin Prodrugs App 20160296600 - Sprogoe; Kennett ;   et al. | 2016-10-13 |
Prodrugs comprising an insulin linker conjugate Grant 9,457,066 - Rau , et al. October 4, 2 | 2016-10-04 |
Long acting insulin composition Grant 9,265,723 - Sprogoe , et al. February 23, 2 | 2016-02-23 |
Prodrugs comprising an insulin linker conjugate Grant 9,138,462 - Rau , et al. September 22, 2 | 2015-09-22 |
Prodrugs Comprising An Insulin Linker Conjugate App 20150258207 - RAU; Harald ;   et al. | 2015-09-17 |
Prodrugs comprising an exendin linker conjugate Grant 9,133,276 - Cleemann , et al. September 15, 2 | 2015-09-15 |
Prodrug Comprising A Drug Linker Conjugate App 20150057221 - Cleemann; Felix ;   et al. | 2015-02-26 |
Prodrug comprising a drug linker conjugate Grant 8,906,847 - Cleemann , et al. December 9, 2 | 2014-12-09 |
Prodrugs Comprising An Exendin Linker Conjugate App 20130189328 - Cleemann; Felix ;   et al. | 2013-07-25 |
Long Acting Insulin Composition App 20120183616 - Sprogoe; Kennett ;   et al. | 2012-07-19 |
Prodrug Comprising A Drug Linker Conjugate App 20110053848 - Cleemann; Felix ;   et al. | 2011-03-03 |
Process For Preparing Enantiomerically Enriched Beta-amino Acid Derivatives App 20090187017 - Berkessel; Albrecht ;   et al. | 2009-07-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.